<p>阿尔法泰克控股公司（NASDAQ:ATEC - 获取免费报告）在覆盖该公司的十二家研究机构中获得了 “适度买入” 的平均评级，Marketbeat.com 报道。一位股票研究分析师给予该股票卖出评级，一位给予持有评级，十位给予买入评级。在过去一年中，覆盖该股票的经纪商的平均一年目标价为 18.5833 美元。</p>
<p>ATEC 已成为多份研究报告的主题。Needham &amp; Company LLC 在 5 月 6 日的研究报告中将阿尔法泰克的目标价从 25.00 美元下调至 14.00 美元，并给予该公司 “买入” 评级。Canaccord Genuity Group 在 5 月 6 日的研究报告中将阿尔法泰克的目标价从 25.00 美元下调至 23.00 美元，并给予该公司 “买入” 评级。Lake Street Capital 在 5 月 6 日的研究报告中重申了 “买入” 评级，并将阿尔法泰克的目标价设定为 15.00 美元。Piper Sandler 在 5 月 6 日的研究报告中重申了 “增持” 评级，并将阿尔法泰克的目标价设定为 14.00 美元（从 25.00 美元下调）。最后，富国银行在 5 月 7 日的研究报告中将阿尔法泰克的目标价从 28.00 美元下调至 14.00 美元，并给予该公司 “增持” 评级。</p>
<p><strong>查看我们关于 ATEC 的最新研究报告</strong></p>
<h2>阿尔法泰克的内部买卖</h2>
<p>在其他新闻中，公司的总法律顾问泰森·艾略特·马歇尔于 3 月 5 日星期四出售了 88,835 股公司的股票，交易价格为每股 12.49 美元，总交易额为 1,109,549.15 美元。交易完成后，总法律顾问直接持有公司 559,459 股股票，价值为 6,987,642.91 美元。此交易代表其持股比例减少了 13.70%。该出售在向 SEC 提交的文件中披露，文件可通过此链接获取。此外，执行副总裁大卫·斯庞塞尔于 3 月 11 日星期三出售了 163,452 股公司的股票，交易价格为每股 12.52 美元，总交易额为 2,046,419.04 美元。交易完成后，执行副总裁直接持有公司 504,932 股股票，价值约为 6,321,748.64 美元。此交易代表其持股比例减少了 24.45%。有关此次出售的更多细节可在官方 SEC 披露中找到。在上个季度，内部人士出售了 629,189 股公司股票，价值为 7,801,589 美元。公司内部人士持有公司股票的 13.48%。</p>
<h2>机构资金流入和流出</h2>
<p>最近，一些对冲基金修改了对该公司的持股。PNC 金融服务集团在第一季度将其在阿尔法泰克的股份增加了 1.5%。PNC 金融服务集团现在拥有 318,319 股该医疗技术公司的股票，价值为 3,463,000 美元，此前在上个季度购买了 4,643 股。独立金融集团在第一季度购买了阿尔法泰克的新头寸，价值约为 431,000 美元。圣所顾问在第一季度购买了阿尔法泰克的新头寸，价值约为 197,000 美元。Emerald Mutual Fund Advisers Trust 在第一季度将其在阿尔法泰克的股份增加了 27.1%。Emerald Mutual Fund Advisers Trust 现在拥有 1,156,826 股该医疗技术公司的股票，价值为 12,586,000 美元，此前在上个季度购买了 246,773 股。最后，Emerald Advisers LLC 在第一季度将其在阿尔法泰克的股份增加了 10.4%。Emerald Advisers LLC 现在拥有 1,807,307 股该医疗技术公司的股票，价值为 19,664,000 美元，此前在上个季度购买了 169,578 股。66.35% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>阿尔法泰克的价格表现</h2>
<p>ATEC 股票在周三开盘价为 7.74 美元。该公司的 50 日移动平均线为 11.09 美元，200 日移动平均线为 15.68 美元。阿尔法泰克的 12 个月低点为 6.82 美元，12 个月高点为 23.29 美元。该公司的流动比率为 1.90，速动比率为 1.12，债务与股本比率为 40.35。该公司的市值为 11.9 亿美元，市盈率为-9.44，贝塔系数为 0.96。</p>
<p>阿尔法泰克（NASDAQ:ATEC - 获取免费报告）最近于 5 月 5 日星期二发布了季度财报。这家医疗技术公司报告的每股收益（EPS）为（0.22）美元，低于分析师一致预期的（0.01）美元，差距为（0.21）美元。阿尔法泰克的净利润率为-15.93%，股本回报率为-1,183.84%。该公司季度收入为 1.9211 亿美元，而分析师预期为 1.9751 亿美元。在去年同期，该公司每股收益为（0.35）美元。阿尔法泰克的收入同比增长了 13.6%。作为一个整体，股票分析师预计阿尔法泰克在当前财年将发布-0.28 的每股收益。</p>
<h2>阿尔法泰克公司简介</h2>
<p>（获取免费报告）</p>
<p>阿尔法泰克控股公司 NASDAQ: ATEC 是一家医疗技术公司，专注于设计、开发和商业化用于外科矫正退行性脊柱疾病的产品。该公司的产品组合以体内植入物、生物制剂、固定装置和手术规划工具为中心，旨在改善脊柱融合手术中的患者结果。阿尔法泰克的旗舰产品包括可定制的体内笼、骨移植材料和专门的仪器，旨在用于微创和开放脊柱手术。</p>
<p>阿尔法泰克成立于 1985 年，最初名为阿尔法泰克脊柱，2018 年更名为阿尔法泰克控股公司，已从单一产品组织发展为脊柱市场的多平台创新者。</p>
<h2>精选故事</h2>
<ul>
<li>我们更看好的五只股票超过 Alphatec</li>
<li>海军催化剂点燃 Odysight 的增长引擎</li>
<li>AST SpaceMobile 因银河 Q1 业绩不佳暴跌：垂直整合能拯救这家 SpaceX 竞争对手吗？</li>
<li>Axon 在财报发布后大涨，但仍比高点下跌超过 50%</li>
<li>可能重新定义苹果夏季反弹的事件</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVRFQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVRFQw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Alphatec 吗？</h2>
<p>在你考虑 Alphatec 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前... 而 Alphatec 并不在名单上。</p>
<p>虽然 Alphatec 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

阿尔法泰克控股

标普健康医疗设备 ETF - SPDR

美国医药设备 ETF - iShares

<p>Alphatec Holdings, Inc.（纳斯达克代码：ATEC）获得了十二家研究公司的 “适度买入” 平均评级。一位分析师将其评级为卖出，一位为持有，十位为买入。平均目标价为 18.58 美元。最近的报告显示，各公司对目标价进行了下调，其中 Needham & Company 和 Wells Fargo 的降幅尤为显著。内部交易活动包括高管的大额出售。对冲基金也调整了其持股，机构投资者持有 66.35% 的股份。ATEC 股票开盘价为 7.74 美元，市值为 11.9 亿美元，负每股收益为（0.22 美元）</p>

<p>Alphatec Holdings, Inc. (NASDAQ:ATEC - Get Free Report) has earned an average rating of &#34;Moderate Buy&#34; from the twelve research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and ten have given a buy recommendation to the company. The average 1 year target price among brokers that have covered the stock in the last year is $18.5833.</p>
<div class="lb-trans"><p>阿尔法泰克控股公司（NASDAQ:ATEC - 获取免费报告）在覆盖该公司的十二家研究机构中获得了 “适度买入” 的平均评级，Marketbeat.com 报道。一位股票研究分析师给予该股票卖出评级，一位给予持有评级，十位给予买入评级。在过去一年中，覆盖该股票的经纪商的平均一年目标价为 18.5833 美元。</p>
</div><p>ATEC has been the subject of a number of research reports. Needham &amp; Company LLC reduced their price target on shares of Alphatec from $25.00 to $14.00 and set a &#34;buy&#34; rating for the company in a research report on Wednesday, May 6th. Canaccord Genuity Group reduced their price target on shares of Alphatec from $25.00 to $23.00 and set a &#34;buy&#34; rating for the company in a research report on Wednesday, May 6th. Lake Street Capital reiterated a &#34;buy&#34; rating and set a $15.00 price target on shares of Alphatec in a research report on Wednesday, May 6th. Piper Sandler reiterated an &#34;overweight&#34; rating and set a $14.00 price target (down from $25.00) on shares of Alphatec in a research report on Wednesday, May 6th. Finally, Wells Fargo &amp; Company reduced their price target on shares of Alphatec from $28.00 to $14.00 and set an &#34;overweight&#34; rating for the company in a research report on Thursday, May 7th.</p>
<div class="lb-trans"><p>ATEC 已成为多份研究报告的主题。Needham &amp; Company LLC 在 5 月 6 日的研究报告中将阿尔法泰克的目标价从 25.00 美元下调至 14.00 美元，并给予该公司 “买入” 评级。Canaccord Genuity Group 在 5 月 6 日的研究报告中将阿尔法泰克的目标价从 25.00 美元下调至 23.00 美元，并给予该公司 “买入” 评级。Lake Street Capital 在 5 月 6 日的研究报告中重申了 “买入” 评级，并将阿尔法泰克的目标价设定为 15.00 美元。Piper Sandler 在 5 月 6 日的研究报告中重申了 “增持” 评级，并将阿尔法泰克的目标价设定为 14.00 美元（从 25.00 美元下调）。最后，富国银行在 5 月 7 日的研究报告中将阿尔法泰克的目标价从 28.00 美元下调至 14.00 美元，并给予该公司 “增持” 评级。</p>
</div><p><strong>View Our Latest Research Report on ATEC</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 ATEC 的最新研究报告</strong></p>
</div><h2>Insider Buying and Selling at Alphatec</h2>
<div class="lb-trans"><h2>阿尔法泰克的内部买卖</h2>
</div><p>In other news, General Counsel Tyson Eliot Marshall sold 88,835 shares of the firm's stock in a transaction that occurred on Thursday, March 5th. The shares were sold at an average price of $12.49, for a total transaction of $1,109,549.15. Following the completion of the transaction, the general counsel directly owned 559,459 shares of the company's stock, valued at $6,987,642.91. This trade represents a 13.70% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP David Sponsel sold 163,452 shares of the firm's stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at an average price of $12.52, for a total transaction of $2,046,419.04. Following the transaction, the executive vice president directly owned 504,932 shares of the company's stock, valued at approximately $6,321,748.64. This trade represents a 24.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 629,189 shares of company stock valued at $7,801,589. Company insiders own 13.48% of the company's stock.</p>
<div class="lb-trans"><p>在其他新闻中，公司的总法律顾问泰森·艾略特·马歇尔于 3 月 5 日星期四出售了 88,835 股公司的股票，交易价格为每股 12.49 美元，总交易额为 1,109,549.15 美元。交易完成后，总法律顾问直接持有公司 559,459 股股票，价值为 6,987,642.91 美元。此交易代表其持股比例减少了 13.70%。该出售在向 SEC 提交的文件中披露，文件可通过此链接获取。此外，执行副总裁大卫·斯庞塞尔于 3 月 11 日星期三出售了 163,452 股公司的股票，交易价格为每股 12.52 美元，总交易额为 2,046,419.04 美元。交易完成后，执行副总裁直接持有公司 504,932 股股票，价值约为 6,321,748.64 美元。此交易代表其持股比例减少了 24.45%。有关此次出售的更多细节可在官方 SEC 披露中找到。在上个季度，内部人士出售了 629,189 股公司股票，价值为 7,801,589 美元。公司内部人士持有公司股票的 13.48%。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of hedge funds have recently modified their holdings of the business. PNC Financial Services Group Inc. increased its stake in shares of Alphatec by 1.5% during the 1st quarter. PNC Financial Services Group Inc. now owns 318,319 shares of the medical technology company's stock worth $3,463,000 after purchasing an additional 4,643 shares in the last quarter. Independent Financial Group LLC purchased a new position in shares of Alphatec during the 1st quarter worth approximately $431,000. Sanctuary Advisors LLC purchased a new position in shares of Alphatec during the 1st quarter worth approximately $197,000. Emerald Mutual Fund Advisers Trust increased its stake in shares of Alphatec by 27.1% during the 1st quarter. Emerald Mutual Fund Advisers Trust now owns 1,156,826 shares of the medical technology company's stock worth $12,586,000 after purchasing an additional 246,773 shares in the last quarter. Finally, Emerald Advisers LLC increased its stake in shares of Alphatec by 10.4% during the 1st quarter. Emerald Advisers LLC now owns 1,807,307 shares of the medical technology company's stock worth $19,664,000 after purchasing an additional 169,578 shares in the last quarter. 66.35% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>最近，一些对冲基金修改了对该公司的持股。PNC 金融服务集团在第一季度将其在阿尔法泰克的股份增加了 1.5%。PNC 金融服务集团现在拥有 318,319 股该医疗技术公司的股票，价值为 3,463,000 美元，此前在上个季度购买了 4,643 股。独立金融集团在第一季度购买了阿尔法泰克的新头寸，价值约为 431,000 美元。圣所顾问在第一季度购买了阿尔法泰克的新头寸，价值约为 197,000 美元。Emerald Mutual Fund Advisers Trust 在第一季度将其在阿尔法泰克的股份增加了 27.1%。Emerald Mutual Fund Advisers Trust 现在拥有 1,156,826 股该医疗技术公司的股票，价值为 12,586,000 美元，此前在上个季度购买了 246,773 股。最后，Emerald Advisers LLC 在第一季度将其在阿尔法泰克的股份增加了 10.4%。Emerald Advisers LLC 现在拥有 1,807,307 股该医疗技术公司的股票，价值为 19,664,000 美元，此前在上个季度购买了 169,578 股。66.35% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Alphatec Price Performance</h2>
<div class="lb-trans"><h2>阿尔法泰克的价格表现</h2>
</div><p>ATEC stock opened at $7.74 on Wednesday. The firm has a 50 day moving average of $11.09 and a 200-day moving average of $15.68. Alphatec has a 12-month low of $6.82 and a 12-month high of $23.29. The company has a current ratio of 1.90, a quick ratio of 1.12 and a debt-to-equity ratio of 40.35. The company has a market cap of $1.19 billion, a price-to-earnings ratio of -9.44 and a beta of 0.96.</p>
<div class="lb-trans"><p>ATEC 股票在周三开盘价为 7.74 美元。该公司的 50 日移动平均线为 11.09 美元，200 日移动平均线为 15.68 美元。阿尔法泰克的 12 个月低点为 6.82 美元，12 个月高点为 23.29 美元。该公司的流动比率为 1.90，速动比率为 1.12，债务与股本比率为 40.35。该公司的市值为 11.9 亿美元，市盈率为-9.44，贝塔系数为 0.96。</p>
</div><p>Alphatec (NASDAQ:ATEC - Get Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The medical technology company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.21). Alphatec had a negative net margin of 15.93% and a negative return on equity of 1,183.84%. The company had revenue of $192.11 million for the quarter, compared to analyst estimates of $197.51 million. During the same quarter in the previous year, the business posted ($0.35) earnings per share. Alphatec's revenue was up 13.6% on a year-over-year basis. As a group, equities analysts expect that Alphatec will post -0.28 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>阿尔法泰克（NASDAQ:ATEC - 获取免费报告）最近于 5 月 5 日星期二发布了季度财报。这家医疗技术公司报告的每股收益（EPS）为（0.22）美元，低于分析师一致预期的（0.01）美元，差距为（0.21）美元。阿尔法泰克的净利润率为-15.93%，股本回报率为-1,183.84%。该公司季度收入为 1.9211 亿美元，而分析师预期为 1.9751 亿美元。在去年同期，该公司每股收益为（0.35）美元。阿尔法泰克的收入同比增长了 13.6%。作为一个整体，股票分析师预计阿尔法泰克在当前财年将发布-0.28 的每股收益。</p>
</div><h2>Alphatec Company Profile</h2>
<div class="lb-trans"><h2>阿尔法泰克公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Alphatec Holdings, Inc NASDAQ: ATEC is a medical technology company focused on the design, development and commercialization of products for the surgical correction of degenerative spinal conditions. The company's portfolio centers on interbody implants, biologics, fixation devices and surgical planning tools intended to improve patient outcomes in spinal fusion procedures. Alphatec's flagship offerings include customizable interbody cages, bone graft materials and specialized instrumentation designed for minimally invasive and open spinal surgeries.</p>
<div class="lb-trans"><p>阿尔法泰克控股公司 NASDAQ: ATEC 是一家医疗技术公司，专注于设计、开发和商业化用于外科矫正退行性脊柱疾病的产品。该公司的产品组合以体内植入物、生物制剂、固定装置和手术规划工具为中心，旨在改善脊柱融合手术中的患者结果。阿尔法泰克的旗舰产品包括可定制的体内笼、骨移植材料和专门的仪器，旨在用于微创和开放脊柱手术。</p>
</div><p>Founded as Alphatec Spine in 1985 and rebranded as Alphatec Holdings in 2018, the company has grown from a single-product organization into a multi-platform innovator in the spine market.</p>
<div class="lb-trans"><p>阿尔法泰克成立于 1985 年，最初名为阿尔法泰克脊柱，2018 年更名为阿尔法泰克控股公司，已从单一产品组织发展为脊柱市场的多平台创新者。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Alphatec</li>
<li>Navy Catalyst Ignites Odysight’s Growth Engine</li>
<li>AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?</li>
<li>Axon Surged After Earnings and Is Still Down Over 50% From Highs</li>
<li>The Event That Could Redefine Apple’s Summer Rally</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过 Alphatec</li>
<li>海军催化剂点燃 Odysight 的增长引擎</li>
<li>AST SpaceMobile 因银河 Q1 业绩不佳暴跌：垂直整合能拯救这家 SpaceX 竞争对手吗？</li>
<li>Axon 在财报发布后大涨，但仍比高点下跌超过 50%</li>
<li>可能重新定义苹果夏季反弹的事件</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVRFQw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=ATEC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Alphatec Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Alphatec 吗？</h2>
</div><p>Before you consider Alphatec, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Alphatec 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alphatec wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前... 而 Alphatec 并不在名单上。</p>
</div><p>While Alphatec currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Alphatec 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Alphatec Holdings, Inc. (NASDAQ:ATEC) Given Average Rating of "Moderate Buy" by Brokerages

Market Beat

Piper Sandler Cos

富国银行

PNC金融服务

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

阿尔法泰克控股公司（NASDAQ:ATEC）被券商给予 “适度买入” 的平均评级